{{Rsnum
|rsid=1014064
|Gene=ACVR2A
|Chromosome=2
|position=147854585
|Orientation=plus
|GMAF=0.388
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ACVR2A
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 37.2 | 54.0 | 8.8
| HCB | 25.7 | 53.7 | 20.6
| JPT | 25.7 | 48.7 | 25.7
| YRI | 58.5 | 34.0 | 7.5
| ASW | 43.9 | 43.9 | 12.3
| CHB | 25.7 | 53.7 | 20.6
| CHD | 18.3 | 48.6 | 33.0
| GIH | 54.5 | 33.7 | 11.9
| LWK | 40.9 | 50.9 | 8.2
| MEX | 15.5 | 70.7 | 13.8
| MKK | 45.5 | 41.7 | 12.8
| TSI | 45.1 | 42.2 | 12.7
| HapMapRevision=28
}}This SNP is located on chromosome 2q22-23, in the activin receptor type 2 gene ([[ACVR2A]]) gene.

A study of 1139 Norwegian women with one or more pre-eclamptic pregnancies and 2269 controls (women with normal pregnancies) identified four SNPs in this region ([[rs1424941]], [[rs1014064]], [[rs2161983]] and [[rs3768687]]) as associated with higher risk for [[pre-eclampsia]].{{PMID|18781190|OA=1
}}

{{PMID Auto
|PMID=19126782
|Title=Genetic association of the activin A receptor gene (ACVR2A) and pre-eclampsia.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}